Respiratory Medicine

Anti-CELA1 KF4 Antibody Prevents Emphysema by Inhibiting Stretch-Mediated Remodeling
Mohit Ojha, Noah Smith, Rashika Joshi, Emily Goodman, Qiang Fan, Richard Schuman, Aleksey Porollo, Rachel L. Zemans, Matthew R. Batie, Michael T. Borchers, Samuel Ammerman, Brian M. Varisco

medRxiv 2020.04.27.20075531; doi: https://doi.org/10.1101/2020.04.27.20075531

Add to Selected Citations
A Model to Predict In-hospital Mortality in Elderly Patients with Community-acquired Pneumonia: a Retrospective Study
Yanting Hao, Hua Zhang, Yingying Yan, Yun Zhu, Fuchun Zhang

medRxiv 2022.04.18.22273956; doi: https://doi.org/10.1101/2022.04.18.22273956

Add to Selected Citations
α1 adrenoreceptor antagonism mitigates extracellular mitochondrial DNA accumulation in lung fibrosis models and in patients with IPF
Genta Ishikawa, Xueyan Peng, John McGovern, Sam Woo, Carrighan Perry, Angela Liu, Sheeline Yu, Alexander Ghincea, Huanxing Sun, Changwan Ryu, Erica L. Herzog

medRxiv 2022.04.06.22273471; doi: https://doi.org/10.1101/2022.04.06.22273471

Add to Selected Citations
Comparing phrenic nerve stimulation using three rapid coils: implications for mechanical ventilation
Kyle G. Boyle, Philipp A. Eichenberger, Patrick Schön, Christina M. Spengler

medRxiv 2022.03.29.22272862; doi: https://doi.org/10.1101/2022.03.29.22272862

Add to Selected Citations
Model-based Bayesian inference of the ventilation distribution in patients with Cystic Fibrosis from multiple breath washout, with comparison to ventilation MRI
Carl A. Whitfield, Alexander Horsley, Oliver E. Jensen, Felix C. Horn, Guilhem J. Collier, Laurie J. Smith, Jim M. Wild

medRxiv 2021.10.01.21264402; doi: https://doi.org/10.1101/2021.10.01.21264402

Add to Selected Citations
Sustained patient use and improved outcomes with digital transformation of a COPD service: RECEIVER trial and DYNAMIC-SCOT COVID-19 scale-up response
A Taylor, A Cushing, M Dow, J Anderson, G McDowell, S Lua, M Manthe, S Padmanabhan, S Burns, P McGinness, DJ Lowe, C Carlin

medRxiv 2022.04.04.22273427; doi: https://doi.org/10.1101/2022.04.04.22273427

Add to Selected Citations
Nonutility of procalcitonin for diagnosing bacterial pneumonia in COVID-19
Avi J. Cohen, Laura R. Glick, Seohyuk Lee, Yukiko Kunitomo, Derek A. Tsang, Sarah Pitafi, Patricia Valda Toro, Ethan Zhang, Rupak Datta, Charles S. Dela Cruz, Samir Gautam

medRxiv 2022.03.29.22272960; doi: https://doi.org/10.1101/2022.03.29.22272960

Add to Selected Citations
A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
Joshua J. Solomon, Sonye Danoff, Felix Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F. Dellaripa, Bibek Gooptu, Robert Vassallo, P. Gerald Cox, Kevin R. Flaherty, Huzaifa I. Adamali, Michael A. Gibbons, Lauren Troy, Ian Forrest, Joseph A. Lasky, Lisa G. Spencer, Jeffrey Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A. Perella, David Lynch, Daniel C. Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary Goldberg, Ivan O. Rosas, the TRAIL1 Network Investigators

medRxiv 2022.04.01.22273270; doi: https://doi.org/10.1101/2022.04.01.22273270

Add to Selected Citations
Using genetic information to define idiopathic pulmonary fibrosis in UK Biobank
Olivia C Leavy, Richard J Allen, Luke M Kraven, Ann Morgan, Martin D Tobin, Jennifer K Quint, R Gisli Jenkins, Louise V Wain

medRxiv 2022.04.01.22273306; doi: https://doi.org/10.1101/2022.04.01.22273306

Add to Selected Citations
Ivacaftor, not ivacaftor/lumacaftor, is associated with lower pulmonary inflammation in preschool cystic fibrosis
Shivanthan Shanthikumar, Sarath Ranganathan, Melanie R. Neeland

medRxiv 2022.03.28.22273066; doi: https://doi.org/10.1101/2022.03.28.22273066

Add to Selected Citations

Respiratory Medicine

Pages